Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
BA.1.1.17ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.1.1.17NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BS.1.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BS.1.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BS.1.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BS.1.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
CM.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
CM.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
CM.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
CM.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BA.2.75.7ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-15397.9France
BA.2.75.7ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.2.75.7ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.2.75.7NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
CA.7ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
CA.7ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
CA.7ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
CA.7NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.453ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.453ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.453ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.453NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.637.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.637.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.637.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.637.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BA.2.79ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BA.2.79ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.2.79ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.2.79NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BG.3ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BG.3ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BG.3ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BG.3NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BA.2.3.10ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BA.2.3.10ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.2.3.10ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.2.3.10NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
KN.1.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
KN.1.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
KN.1.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
KN.1.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
XBB.1.10ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
XBB.1.10ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBB.1.10ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.1.10NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BQ.1.1.61ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BQ.1.1.61ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BQ.1.1.61ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BQ.1.1.61NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used